Department of Surgical and Radiological Sciences, University of California Davis, Davis, California.
College of Agricultural and Environmental Sciences, University of California Davis, Davis, California.
Vet Comp Oncol. 2020 Jun;18(2):191-198. doi: 10.1111/vco.12531. Epub 2019 Aug 29.
Localized radiation therapy can be an effective treatment for cancer but is associated with localized and systemic side effects. Several studies have noted changes in complete blood count (CBC) parameters including decreases in the absolute lymphocyte count (ALC) and increases in the neutrophil:lymphocyte ratio (NLR). These changes could reflect immunosuppression and may contribute to decreased efficacy of immunotherapies used to treat cancer. We hypothesized that dogs would demonstrate decreased ALCs during a course of radiotherapy. A retrospective study was conducted on 203 dogs receiving definitive-intent radiotherapy. Demographic information, CBC values and details of the radiotherapy protocol were collected. The mean lymphocyte count pre-treatment was 1630.68 cells/μL (SD ± 667.56) with a mean NLR of 3.66 (SD ± 4.53). The mean lymphocyte count mid-treatment was 1251.07 cells/μL (SD ± 585.96) and the mean NLR was 6.23 (SD ± 4.99). There was a significant decrease in the mean lymphocyte count by 351.41 lymphocytes/μL (SD ± 592.32) between pre-treatment and mid-treatment (P < .0001), and a corresponding significant increase in the mean NLR of 0.93 (P = .02). Lymphopenia grade increased in 33.5% of dogs and was significant (P = .03). The ALC decrease was not correlated with the volume irradiated (P = .27), but correlated with the irradiated volume:body weight ratio (P = .03). A subset of patients (n = 35) with additional CBCs available beyond the mid-treatment time point demonstrated significant and sustained downward trends in the ALC compared with baseline. Although severe lymphopenia was rare, these decreases, especially if sustained, could impact adjuvant therapy for their cancer.
局部放射治疗可以是癌症的有效治疗方法,但与局部和全身副作用有关。一些研究注意到全血细胞计数 (CBC) 参数的变化,包括绝对淋巴细胞计数 (ALC) 下降和中性粒细胞与淋巴细胞比值 (NLR) 升高。这些变化可能反映免疫抑制,并可能导致用于治疗癌症的免疫疗法效果降低。我们假设狗在放射治疗过程中会表现出 ALC 下降。对 203 只接受确定性意向放射治疗的狗进行了回顾性研究。收集了人口统计学信息、CBC 值和放射治疗方案的详细信息。治疗前的平均淋巴细胞计数为 1630.68 个/μL(SD ± 667.56),平均 NLR 为 3.66(SD ± 4.53)。治疗中期的平均淋巴细胞计数为 1251.07 个/μL(SD ± 585.96),平均 NLR 为 6.23(SD ± 4.99)。治疗前和中期之间的平均淋巴细胞计数下降了 351.41 个/μL(SD ± 592.32)(P<.0001),平均 NLR 相应增加了 0.93(P =.02)。33.5%的狗的淋巴细胞减少程度增加,差异具有统计学意义(P =.03)。ALC 下降与照射体积无关(P =.27),但与照射体积与体重比相关(P =.03)。在治疗中期后有更多 CBC 可用的一组患者(n = 35)与基线相比,ALC 呈显著且持续的下降趋势。尽管严重的淋巴细胞减少很少见,但这些下降,尤其是持续下降,可能会影响癌症的辅助治疗。